The medical device manufacturer Langer Medical announces strategic partnership in the UK with Axiom Devices, an affiliate company of Axiom Neuromonitoring.
Founded in 2013, Axiom Neuromonitoring has become a leading neuromonitoring service in the UK, providing for over 45 hospitals nationwide. Their commitment to cutting-edge technology, continuous innovation, and dedication to patient safety aligns seamlessly with Langer Medical's portfolio and mission of prioritizing excellence in healthcare delivery.
This pivotal collaboration designates Axiom Devices as the exclusive distributor of Langer Medical’s state-of-the-art neuromonitoring products within the United Kingdom.
Advancing Surgical Procedures with Leading-Edge Technology
By merging Axiom Devices' expertise in clinical neuromonitoring with the advanced technology of Langer Medical, a powerful synergy is set to enhance the availability and quality of neuromonitoring solutions throughout the country, significantly improving patient care and outcomes in surgical procedures where the nervous system is at risk.
Through this collaboration, Axiom Devices will provide UK healthcare professionals access to the most advanced technologies in the neuromonitoring field. Dr. Langer's equipment, known for its precision and reliability, will enable surgeons to more accurately monitor neural activity during procedures. This is expected to markedly reduce the risk of postoperative complications and to enhance surgical outcomes.
A Shared Commitment to Innovation and Excellence
The partnership between Axiom Devices and Langer Medical is built on a mutual commitment to innovation, excellence, and the advancement of neuromonitoring practices. Both companies are devoted to using technology to better patient care, making this collaboration a perfect strategic fit.
"At Langer Medical, we are dedicated to forging partnerships that drive positive outcomes for patients," said Christian Hartmann, Managing Director of Langer Medical. "We are excited to join forces with Axiom Neuromonitoring, whose mission closely resonates with our own values of elevating patient care standards through innovation and collaboration. Their expertise in clinical neuromonitoring and their affiliation with Axiom Neuromonitoring make them the ideal partner to bring our advanced IONM equipment to the UK market. "
"We are excited to partner with Dr. Langer, a company at the cutting edge of neuromonitoring technology," said Dale Darbyshire, CEO of Axiom Devices. "This partnership underscores our commitment within the Axiom Group to provide the UK healthcare sector with superior neuromonitoring services and equipment, thereby enhancing the quality of patient care for those undergoing neurological procedures."
By combining their expertise and resources, Langer Medical and Axiom Devices are confident in reaching their ambitious goals to revolutionise Britain’s neuromonitoring landscape, empower healthcare providers and sustainably improve patient outcomes across the UK.
In the process, both companies can leverage Brainlab UK's already established clinical network (Langer Medical has been part of "The Brainlab Companies" since 2022), which will further benefit a successful market penetration for the near future.
Founded in 2013, Axiom Neuromonitoring has become a leading neuromonitoring service in the UK, providing for over 45 hospitals nationwide. Their commitment to cutting-edge technology, continuous innovation, and dedication to patient safety aligns seamlessly with Langer Medical's portfolio and mission of prioritizing excellence in healthcare delivery.
This pivotal collaboration designates Axiom Devices as the exclusive distributor of Langer Medical’s state-of-the-art neuromonitoring products within the United Kingdom.
Advancing Surgical Procedures with Leading-Edge Technology
By merging Axiom Devices' expertise in clinical neuromonitoring with the advanced technology of Langer Medical, a powerful synergy is set to enhance the availability and quality of neuromonitoring solutions throughout the country, significantly improving patient care and outcomes in surgical procedures where the nervous system is at risk.
Through this collaboration, Axiom Devices will provide UK healthcare professionals access to the most advanced technologies in the neuromonitoring field. Dr. Langer's equipment, known for its precision and reliability, will enable surgeons to more accurately monitor neural activity during procedures. This is expected to markedly reduce the risk of postoperative complications and to enhance surgical outcomes.
A Shared Commitment to Innovation and Excellence
The partnership between Axiom Devices and Langer Medical is built on a mutual commitment to innovation, excellence, and the advancement of neuromonitoring practices. Both companies are devoted to using technology to better patient care, making this collaboration a perfect strategic fit.
"At Langer Medical, we are dedicated to forging partnerships that drive positive outcomes for patients," said Christian Hartmann, Managing Director of Langer Medical. "We are excited to join forces with Axiom Neuromonitoring, whose mission closely resonates with our own values of elevating patient care standards through innovation and collaboration. Their expertise in clinical neuromonitoring and their affiliation with Axiom Neuromonitoring make them the ideal partner to bring our advanced IONM equipment to the UK market. "
"We are excited to partner with Dr. Langer, a company at the cutting edge of neuromonitoring technology," said Dale Darbyshire, CEO of Axiom Devices. "This partnership underscores our commitment within the Axiom Group to provide the UK healthcare sector with superior neuromonitoring services and equipment, thereby enhancing the quality of patient care for those undergoing neurological procedures."
By combining their expertise and resources, Langer Medical and Axiom Devices are confident in reaching their ambitious goals to revolutionise Britain’s neuromonitoring landscape, empower healthcare providers and sustainably improve patient outcomes across the UK.
In the process, both companies can leverage Brainlab UK's already established clinical network (Langer Medical has been part of "The Brainlab Companies" since 2022), which will further benefit a successful market penetration for the near future.
